{"schema_version":"secwatch.filing_event.v1","accession":"0001021771-24-000180","form_type":"8-K","ticker":"BRTX","cik":"0001505497","company_name":"BioRestorative Therapies, Inc.","filed_at":"2024-09-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.288813+00:00","generated_at":"2026-05-31T02:22:42.600845+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.15,"confidence":"high","headline":"BioRestorative shareholders approve doubling of stock incentive plan shares to 6.85M","bullets":["Class I director Nickolay Kukekov re-elected with 2,050,111 votes for, 135,114 withheld, 2,048,738 broker non-votes.","Amendment to 2021 Stock Incentive Plan approved: 1,647,022 for, 518,921 against, 19,282 abstentions, 2,048,738 broker non-votes. Authorized shares increased from 3,850,000 to 6,850,000.","Marcum LLP ratified as auditor for FY2024: 4,152,145 for, 18,696 against, 63,122 abstentions.","Annual meeting held September 19, 2024; all three proposals passed."],"urls":{"canonical":"https://secwatch.observer/filing/0001021771-24-000180","json":"https://secwatch.observer/filing/0001021771-24-000180.json","markdown":"https://secwatch.observer/filing/0001021771-24-000180.md","text":"https://secwatch.observer/filing/0001021771-24-000180.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1505497/000102177124000180/0001021771-24-000180-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1505497/000102177124000180/brt8k91924.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T02:22:42.600845+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}